WallStSmart

Coca-Cola European Partners PLC (CCEP)vsUnited-Guardian Inc (UG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 191011% more annual revenue ($20.90B vs $10.94M). UG leads profitability with a 21.6% profit margin vs 9.3%. UG appears more attractively valued with a PEG of 1.13. UG earns a higher WallStSmart Score of 71/100 (B).

CCEP

Buy

57

out of 100

Grade: C

Growth: 6.7Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

UG

Strong Buy

71

out of 100

Grade: B

Growth: 6.7Profit: 8.0Value: 8.0Quality: 7.3
Piotroski: 3/9Altman Z: 7.08
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CCEP.

UGUndervalued (+36.2%)

Margin of Safety

+36.2%

Fair Value

$10.33

Current Price

$6.99

$3.34 discount

UndervaluedFair: $10.33Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.3/10
Return on EquityProfitability
42.9%10/10

Every $100 of equity generates 43 in profit

EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

UG6 strengths · Avg: 8.5/10
Altman Z-ScoreHealth
7.0810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.4%8/10

Strong operational efficiency at 22.4%

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.383/10

Elevated debt levels

PEG RatioValuation
2.722/10

Expensive relative to growth rate

UG2 concerns · Avg: 3.0/10
Market CapQuality
$32.25M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity, EPS Growth, Free Cash Flow.

Bull Case : UG

The strongest argument for UG centers on Altman Z-Score, Profit Margin, P/E Ratio. Profitability is solid with margins at 21.6% and operating margin at 22.4%. Revenue growth of 15.8% demonstrates continued momentum.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : UG

The primary concerns for UG are Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

CCEP profiles as a value stock while UG is a growth play — different risk/reward profiles.

UG carries more volatility with a beta of 0.97 — expect wider price swings.

UG is growing revenue faster at 15.8% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

UG scores higher overall (71/100 vs 57/100), backed by strong 21.6% margins and 15.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

United-Guardian Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. The company is headquartered in Hauppauge, New York.

Want to dig deeper into these stocks?